Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., University of Iowa 2010
• 

  Duke Appointment History

  • Assistant Professor in Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013 - 2020
• Research
• 

  Selected Grants

  • Integrated Acoustofluidic Plasmonic Molecular Diagnostic System for Detecting MicroRNA Biomarkers awarded by National Institutes of Health 2020 - 2023
  • Race-Related Alternative Splicing: Novel Targets in Prostate Cancer awarded by National Institutes of Health 2017 - 2022
  • Immune correlates of immunotherapy responses in renal cell carcinoma awarded by Kidney Cancer Association 2019 - 2021
  • Carbohydrate and Prostate Study 1 and 2 awarded by Institute for Medical Research, Inc. 2020 - 2021
  • Defining the Relevant Immune Checkpoints Expressed on Metastatic Prostate Cancer Circulating Tumor Cells awarded by Janssen Research & Development, LLC 2016 - 2021
  • A Limited-angle Intra-fractional Verification (LIVE) System for SBRT Treatments awarded by National Institutes of Health 2014 - 2020
  • Validation and interrogation of differentially expressed and alternatively spliced genes in African American prostate cancer awarded by Department of Defense 2014 - 2020
  • Therapeutic targeting of B7-H3 to reverse prostate cancer treatment resistance. awarded by Department of Defense 2016 - 2020
  • PSA for Taofik Oyekunle awarded by Institute for Medical Research, Inc. 2017 - 2020
  • PSA for Lauren Howard awarded by Institute for Medical Research, Inc. 2014 - 2020
  • Developing knowledge models to enable rapid learning in radiation therapy awarded by National Institutes of Health 2016 - 2020
  • PSA - Lauren Howard - A Retrospective Description of Patient Characteristics, Management, and Outcomes awarded by Institute for Medical Research, Inc. 2017 - 2020
  • Innovative Biomarker-Integrated Clinical Trial Design and Analysis awarded by University of North Carolina - Chapel Hill 2015 - 2020
  • Statistical/Computational Methods for Pharmacogenomics and Individualized Therapy awarded by University of North Carolina - Chapel Hill 2015 - 2020
  • Bayer-Exini Radium-223 Retrospective Study awarded by Bayer Healthcare Pharmaceuticals Inc 2016 - 2019
  • Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy for Prostate Cancer awarded by University of California - Los Angeles 2017 - 2019
  • Novel Immune Modulating Cellular Vaccine for Prostate Cancer Immunotherapy awarded by Department of Defense 2013 - 2017
  • A Pilot Study on H.O.P.E: Helping Ovarian Cancer Patients Cope with Disease Recurrence awarded by Foundation for Women's Cancer 2014 - 2016
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Brown, Landon C., Matthew D. Tucker, Ramy Sedhom, Eric B. Schwartz, Jason Zhu, Chester Kao, Matthew K. Labriola, et al. “LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types.” J Immunother Cancer 9, no. 3 (March 2021). https://doi.org/10.1136/jitc-2020-001792.
       Full Text  Open Access Copy  Link to Item
    • Brown, Landon C., Jason Zhu, Matthew K. Labriola, Yuan Wu, Sachica Cheris, Xin Liu, Kathryn Perkinson, et al. “PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma.” Clin Genitourin Cancer 18, no. 6 (December 2020): 509–13. https://doi.org/10.1016/j.clgc.2020.03.020.
       Full Text  Link to Item
    • Halabi, Susan, Sandipan Dutta, Yuan Wu, and Aiyi Liu. “Score and deviance residuals based on the full likelihood approach in survival analysis.” Pharm Stat 19, no. 6 (November 2020): 940–54. https://doi.org/10.1002/pst.2047.
       Full Text  Link to Item
    • Wu, Yuan, Xiaofei Wang, Jiaxing Lin, Beilin Jia, and Kouros Owzar. “Predictive accuracy of markers or risk scores for interval censored survival data.” Stat Med 39, no. 18 (August 15, 2020): 2437–46. https://doi.org/10.1002/sim.8547.
       Full Text  Link to Item
    • Freedland, Stephen J., Jenifer Allen, Aubrey Jarman, Taofik Oyekunle, Andrew J. Armstrong, Judd W. Moul, Howard M. Sandler, et al. “A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2).” Clin Cancer Res 26, no. 12 (June 15, 2020): 3035–43. https://doi.org/10.1158/1078-0432.CCR-19-3873.
       Full Text  Link to Item
    • Song, Erin J., Corbin D. Jacobs, Manisha Palta, Christopher G. Willett, Yuan Wu, and Brian G. Czito. “Evaluating treatment protocols for rectal squamous cell carcinomas: the Duke experience and literature.” J Gastrointest Oncol 11, no. 2 (April 2020): 242–49. https://doi.org/10.21037/jgo.2018.11.02.
       Full Text  Link to Item
    • Zhang, Jiahan, Yaorong Ge, Yang Sheng, Chunhao Wang, Jiang Zhang, Yuan Wu, Qiuwen Wu, Fang-Fang Yin, and Q Jackie Wu. “Knowledge-Based Tradeoff Hyperplanes for Head and Neck Treatment Planning.” Int J Radiat Oncol Biol Phys 106, no. 5 (April 1, 2020): 1095–1103. https://doi.org/10.1016/j.ijrobp.2019.12.034.
       Full Text  Link to Item
    • Bitting, Rhonda L., Patrick Healy, Daniel J. George, Monika Anand, Sung Kim, Tina Mayer, Carol Winters, et al. “Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.” Eur Urol Oncol, February 13, 2020. https://doi.org/10.1016/j.euo.2020.01.005.
       Full Text  Link to Item
    • Jacobs, Corbin D., Jacob Trotter, Manisha Palta, Michael J. Moravan, Yuan Wu, Christopher G. Willett, W Robert Lee, and Brian G. Czito. “Multi-Institutional Analysis of Synchronous Prostate and Rectosigmoid Cancers.” Front Oncol 10 (2020): 345. https://doi.org/10.3389/fonc.2020.00345.
       Full Text  Link to Item
    • Holl, Eda K., Megan A. McNamara, Patrick Healy, Monika Anand, Raoul S. Concepcion, Coleman D. Breland, Igor Dumbudze, et al. “Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients.” Prostate Cancer Prostatic Dis 22, no. 4 (December 2019): 588–92. https://doi.org/10.1038/s41391-019-0144-3.
       Full Text  Link to Item
    • Zhu, Jason, Matthew Tucker, Daniele Marin, Rajan T. Gupta, Patrick Healy, Michael Humeniuk, Casey Jarvis, et al. “Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer.” Urol Oncol 37, no. 11 (November 2019): 813.e1-813.e9. https://doi.org/10.1016/j.urolonc.2019.06.015.
       Full Text  Link to Item
    • Tucker, Matthew D., Jason Zhu, Daniele Marin, Rajan T. Gupta, Santosh Gupta, William R. Berry, Sundhar Ramalingam, et al. “Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer.” Cancer Med 8, no. 10 (August 2019): 4644–55. https://doi.org/10.1002/cam4.2375.
       Full Text  Link to Item
    • Wu, Yuan, Christina D. Chambers, and Ronghui Xu. “Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion.” Lifetime Data Anal 25, no. 3 (July 2019): 507–28. https://doi.org/10.1007/s10985-018-9445-4.
       Full Text  Link to Item
    • Li, Zhiguo, Xiaofei Wang, Yuan Wu, and Kouros Owzar. “Sample size calculation for studies with grouped survival data.” Stat Med 37, no. 27 (November 30, 2018): 3904–17. https://doi.org/10.1002/sim.7847.
       Full Text  Open Access Copy  Link to Item
    • Aminsharifi, Alireza, Lauren Howard, Yuan Wu, Amanda De Hoedt, Charlotte Bailey, Stephen J. Freedland, and Thomas J. Polascik. “Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index.” J Urol 200, no. 4 (October 2018): 758–66. https://doi.org/10.1016/j.juro.2018.05.016.
       Full Text  Link to Item
    • Tandberg, Daniel J., Taofik Oyekunle, W Robert Lee, Yuan Wu, Joseph K. Salama, and Bridget F. Koontz. “Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens.” Int J Radiat Oncol Biol Phys 101, no. 2 (June 1, 2018): 396–405. https://doi.org/10.1016/j.ijrobp.2018.02.002.
       Full Text  Link to Item
    • Torok, Jordan A., Yuan Wu, Junzo Chino, Leonard R. Prosnitz, Anne W. Beaven, Grace J. Kim, and Chris R. Kelsey. “Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.” Anticancer Res 38, no. 5 (May 2018): 2875–81. https://doi.org/10.21873/anticanres.12533.
       Full Text  Link to Item
    • Humeniuk, Michael S., Rajan T. Gupta, Patrick Healy, Megan McNamara, Sundhar Ramalingam, Michael Harrison, Daniel George, Tian Zhang, Yuan Wu, and Andrew J. Armstrong. “Platinum sensitivity in metastatic prostate cancer: does histology matter?” Prostate Cancer Prostatic Dis 21, no. 1 (April 2018): 92–99. https://doi.org/10.1038/s41391-017-0017-6.
       Full Text  Link to Item
    • Song, Erin J., Jordan Torok, Yuan Wu, Junzo Chino, Leonard R. Prosnitz, Anne W. Beaven, and Chris R. Kelsey. “Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.” Clin Lymphoma Myeloma Leuk 18, no. 2 (February 2018): 145–51. https://doi.org/10.1016/j.clml.2017.12.007.
       Full Text  Link to Item
    • Ramalingam, Sundhar, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy, Yuan Wu, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang. “Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.” Urol Oncol 35, no. 6 (June 2017): 418–24. https://doi.org/10.1016/j.urolonc.2016.12.016.
       Full Text  Link to Item
    • Longo, Thomas, Kathleen F. McGinley, Jennifer A. Freedman, Wiguins Etienne, Yuan Wu, Alexander Sibley, Kouros Owzar, et al. “Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.” Eur Urol 70, no. 5 (November 2016): 714–17. https://doi.org/10.1016/j.eururo.2016.07.049.
       Full Text  Link to Item
    • Geradts, Joseph, Jeffrey Groth, Yuan Wu, and Genglin Jin. “Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).” Breast Cancer Res Treat 157, no. 3 (June 2016): 447–59. https://doi.org/10.1007/s10549-016-3838-4.
       Full Text  Link to Item
    • Ramalingam, Sundhar, David J. Sermer, Rajan Gupta, Patrick Healy, Yuan Wu, Daniel J. George, Andrew J. Armstrong, and Michael Roger Harrison. “Changes in skeletal muscle cross sectional area (CSA) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZ).” Journal of Clinical Oncology 34, no. 15_suppl (May 20, 2016): e16601–e16601. https://doi.org/10.1200/jco.2016.34.15_suppl.e16601.
       Full Text
    • Ludmir, Ethan B., Ritu Arya, Yuan Wu, Manisha Palta, Christopher G. Willett, and Brian G. Czito. “Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.” Ann Surg Oncol 23, no. 3 (March 2016): 856–62. https://doi.org/10.1245/s10434-015-4907-3.
       Full Text  Link to Item
    • Lu, Chia-Lun, Shuang Wang, Zhanglong Ji, Yuan Wu, Li Xiong, Xiaoqian Jiang, and Lucila Ohno-Machado. “WebDISCO: a web service for distributed cox model learning without patient-level data sharing.” J Am Med Inform Assoc 22, no. 6 (November 2015): 1212–19. https://doi.org/10.1093/jamia/ocv083.
       Full Text  Link to Item
    • Torok, Jordan A., Yuan Wu, Leonard R. Prosnitz, Grace J. Kim, Anne W. Beaven, Louis F. Diehl, and Chris R. Kelsey. “Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.” Int J Radiat Oncol Biol Phys 92, no. 1 (May 1, 2015): 54–59. https://doi.org/10.1016/j.ijrobp.2015.02.003.
       Full Text  Link to Item
    • Wu, Yuan, Xiaoqian Jiang, Shuang Wang, Wenchao Jiang, Pinghao Li, and Lucila Ohno-Machado. “Grid multi-category response logistic models.” Bmc Med Inform Decis Mak 15 (February 18, 2015): 10. https://doi.org/10.1186/s12911-015-0133-y.
       Full Text  Link to Item
    • Ludmir, Ethan B., Manisha Palta, Xuefeng Zhang, Yuan Wu, Christopher G. Willett, and Brian G. Czito. “Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.” J Gastrointest Oncol 5, no. 6 (December 2014): 401–7. https://doi.org/10.3978/j.issn.2078-6891.2014.053.
       Full Text  Link to Item
    • Jiang, Xiaoqian, Yuan Wu, Keith Marsolo, and Lucila Ohno-Machado. “Development of a web service for analysis in a distributed network.” Egems (Wash Dc) 2, no. 1 (2014): 1053. https://doi.org/10.13063/2327-9214.1053.
       Full Text  Open Access Copy  Link to Item
    • Kim, J., E. Levy, A. Ferbrache, P. Stepanowsky, C. Farcas, S. Wang, S. Brunner, T. Bath, Y. Wu, and L. Ohno-Machado. “MAGI: a Node. js web service for fast MicroRNA-Seq Analysis in a GPU Infrastructure.” Bioinformatics, 2014. https://doi.org/10.1093/bioinformatics/btu377.
       Full Text
    • Ludmir, E. B., M. Palta, X. Zhang, Y. Wu, C. G. Willett, and B. G. Czito. “Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.” Journal of Gastrointestinal Oncology 5, no. 6 (January 1, 2014): 401–7. https://doi.org/10.3978/j.issn.2078-6891.2014.05.
       Full Text
    • Jiang, Wenchao, Pinghao Li, Shuang Wang, Yuan Wu, Meng Xue, Lucila Ohno-Machado, and Xiaoqian Jiang. “WebGLORE: a web service for Grid LOgistic REgression.” Bioinformatics 29, no. 24 (December 15, 2013): 3238–40. https://doi.org/10.1093/bioinformatics/btt559.
       Full Text  Link to Item
    • Wu, Y. “B-Spline-based sieve estimation in survival analysis.” Annals of Biometrics and Biostatistics 1, no. 1 (July 5, 2013): 1–3.
    • Wang, Shuang, Xiaoqian Jiang, Yuan Wu, Lijuan Cui, Samuel Cheng, and Lucila Ohno-Machado. “EXpectation Propagation LOgistic REgRession (EXPLORER): distributed privacy-preserving online model learning.” J Biomed Inform 46, no. 3 (June 2013): 480–96. https://doi.org/10.1016/j.jbi.2013.03.008.
       Full Text  Link to Item
    • Botto, Lorenzo D., Timothy Flood, Julian Little, Mark N. Fluchel, Sergey Krikov, Marcia L. Feldkamp, Yuan Wu, Rhinda Goedken, Soman Puzhankara, and Paul A. Romitti. “Cancer risk in children and adolescents with birth defects: a population-based cohort study.” Plos One 8, no. 7 (2013): e69077. https://doi.org/10.1371/journal.pone.0069077.
       Full Text  Link to Item
    • Ramirez, Marizen, Yuan Wu, Sheryl Kataoka, Marleen Wong, Jingzhen Yang, Corinne Peek-Asa, and Bradley Stein. “Youth violence across multiple dimensions: a study of violence, absenteeism, and suspensions among middle school children.” J Pediatr 161, no. 3 (September 2012): 542-546.e2. https://doi.org/10.1016/j.jpeds.2012.03.014.
       Full Text  Link to Item
    • Wu, Yuan, Xiaoqian Jiang, Jihoon Kim, and Lucila Ohno-Machado. “Grid Binary LOgistic REgression (GLORE): building shared models without sharing data.” J Am Med Inform Assoc 19, no. 5 (September 2012): 758–64. https://doi.org/10.1136/amiajnl-2012-000862.
       Full Text  Link to Item
    • Wu, Y., and Y. Zhang. “Partially monotone tensor spline estimation of the joint distribution function with bivariate current status data.” Annals of Statistics 40, no. 3 (June 1, 2012): 1609–36. https://doi.org/10.1214/12-AOS1016.
       Full Text  Open Access Copy
    • Wu, Y., and X. Gao. “Sieve Estimation with Bivariate Interval Censored Data.” Journal of Statistics: Advances in Theory and Applications 5 (2011): 37–61.

  • Book Sections

    • Wu, Yuan, and Susan Halabi. “Interval Censoring.” In Textbook of Clinical Trials in Oncology A Statistical Perspective, edited by Susan Halabi and Stefan Michiels, 493–510. CRC Press, 2019.

  • Conference Papers

    • Brown, Landon Carter, Ramy Sedhom, Eric B. Schwartz, Jason Zhu, Chester Kao, Matthew D. Tucker, Matthew Labriola, et al. “Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint inhibitors across multiple tumor types.” In Journal of Clinical Oncology, Vol. 38, 2020.
       Link to Item
    • Zhang, Tian, Yuan Wu, Anika Agarwal, Mark D. Starr, Marco Reyes-Martinez, Monika Anand, Daniella Runyambo, et al. “Longitudinal multiplex cytokine analysis for patients (pts) with metastatic renalcell carcinoma (mRCC) treated with ipilimumab/nivolumab (I plus N).” In Journal of Clinical Oncology, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.
       Link to Item
    • Mara, Alexandria, Jason Zhu, Yuan Wu, Tom Callis, Shan Yang, Edward D. Esplin, Robert L. Nussbaum, et al. “Prevalence of pathogenic germline variants in DNA repair by race, age, and ethnicity in men with prostate cancer.” In Journal of Clinical Oncology, 37:5062–5062. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.5062.
       Full Text
    • Zhang, Tian, Bridget F. Koontz, Scott T. Tagawa, Himanshu Nagar, Rhonda L. Bitting, Bart Frizzell, Julia Rasmussen, et al. “A phase II Salvage Trial of AR Inhibition with ADT and Apalutamide with Radiation therapy followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (STARTAR).” In Journal of Clinical Oncology, 37:TPS5097–TPS5097. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.tps5097.
       Full Text
    • Zhu, Jason, Matthew D. Tucker, Chester Kao, Matthew Labriola, Sachica Cheris, Michael B. Datto, Yuan Wu, et al. “Immune checkpoint inhibitor response in tumors with LRP1B variants.” In Journal of Clinical Oncology, 37:e14291–e14291. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.e14291.
       Full Text
    • Armstrong, Andrew J., Rhonda L. Bitting, Patrick Healy, Daniel J. George, Sung Kim, Tina M. Mayer, Carolyn Winters, et al. “Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial.” In Journal of Clinical Oncology, 37:29–29. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.29.
       Full Text
    • Harrison, Michael Roger, Michel Khouri, Andrew J. Armstrong, Tian Zhang, Megan Ann McNamara, Monika Anand, Ellen Bratt, et al. “PEAX: Men with metastatic castrate-resistant prostate cancer (mCRPC) treated with either sipuleucel-T (SIP-T), enzalutamide (ENZA) or abiraterone acetate (ABI) undergoing cardiopulmonary exercise testing (CPET).” In Journal of Clinical Oncology, 37:281–281. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.281.
       Full Text
    • Jacobs, Corbin, Jacob Trotter, Manisha Palta, Yuan Wu, Christopher Willett, W Robert Lee, and Brian G. Czito. “Multi-institutional analysis of synchronous prostate and rectosigmoid cancers.” In Journal of Clinical Oncology, 37:33–33. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.33.
       Full Text
    • Tucker, Matthew D., Jason Zhu, William R. Berry, Sundhar Ramalingam, Tian Zhang, Michael Roger Harrison, Yuan Wu, Patrick Healy, Daniel J. George, and Andrew J. Armstrong. “Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, 37:172–172. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.172.
       Full Text
    • Harrison, M. R., P. G. Davis, M. G. Khouri, R. T. Gupta, A. J. Armstrong, M. A. McNamara, T. Zhang, et al. “EXTEND: Safety and efficacy of exercise training in men receiving enzalutamide (ENZ) in combination with conventional androgen deprivation therapy (ADT) for hormone naïve prostate cancer (HSPC).” In Ann Oncol, 29 Suppl 8:viii623–24, 2018. https://doi.org/10.1093/annonc/mdy300.064.
       Full Text  Link to Item
    • Humeniuk, Michael Sandon, Rajan T. Gupta, Megan Ann McNamara, Sundhar Ramalingam, Michael Roger Harrison, Daniel J. George, Yuan Wu, Patrick Healy, and Andrew J. Armstrong. “Association of neuroendocrine phenotype with platinum chemotherapy outcomes in men with metastatic prostate cancer.” In Journal of Clinical Oncology, 35:e16532–e16532. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e16532.
       Full Text
    • Ludmir, E. B., M. Palta, Y. Wu, C. G. Willett, and B. G. Czito. “Definitive Chemoradiation Therapy for Cervical Esophageal Carcinoma: A Single-Institution Experience.” In International Journal of Radiation Oncology*Biology*Physics, 90:S348–S348. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1135.
       Full Text
    • Torok, J., L. R. Prosnitz, M. Palta, Y. Wu, A. Beaven, L. Diehl, and C. R. Kelsey. “Low-Dose Consolidation Radiation Therapy for Early-Stage Unfavorable Hodgkin Lymphoma.” In International Journal of Radiation Oncology*Biology*Physics, 90:S672–73. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1979.
       Full Text
    • Jiang, Xiaoqian, Jihoon Kim, Yuan Wu, Shuang Wang, and Lucila Ohno-Machado. “Selecting cases for whom additional tests can improve prognostication.” In Amia Annu Symp Proc, 2012:1260–68, 2012.
       Link to Item
    • Wu, Y., X. Jiang, J. Kim, and L. Ohno-Machado. “I-spline Smoothing for Calibrating Predictive Models,” 39–46, 2012.
    • Wu, Yuan, Xiaoqian Jiang, and Lucila Ohno-Machado. “Preserving Institutional Privacy in Distributed binary Logistic Regression.” In Amia Annu Symp Proc, 2012:1450–58, 2012.
       Link to Item
• Teaching & Mentoring
• 

  Recent Courses

  • BIOSTAT 903: Advanced Survival Analysis 2021
  • BIOSTAT 903: Advanced Survival Analysis 2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.